Myriad Genetics,. Stock Forecast
Recent Myriad Genetics,. Stock Price |
|
Myriad Genetics,. Stock Forecast Price |
$21.40 |
+15.98% |
$24.82 |
As of 2024-03-28
Recent Myriad Genetics,. Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
3 |
3 |
3 |
3 |
Buy ratings: |
1 |
1 |
1 |
1 |
Hold ratings: |
5 |
5 |
5 |
6 |
Sell ratings: |
1 |
1 |
1 |
1 |
Strong sell ratings: |
1 |
1 |
1 |
1 |
Average rating: |
2.64 |
2.64 |
2.64 |
2.67 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
The presented Myriad Genetics,. stock forecast (traded under symbol MYGN), for forward-twelve-months price target as shown at the top of this page, gives you the average Myriad Genetics,. stock forecast for forward target price for symbol MYGN, across the 11 analysts covering Myriad Genetics,. (MYGN), as reported in
data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Myriad Genetics,. stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Myriad Genetics,. stock forecast and half had a lower Myriad Genetics,. stock forecast) was $25.0 as of 2024-03-28 (which is a different mathematical metric versus taking the average or mean), while the
highest Myriad Genetics,. stock forecast in the analyst group was $31.0, and the lowest Myriad Genetics,. stock forecast in the analyst group was
$17.0, with a standard deviation of $3.682. Get the latest Zacks research report on MYGN — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
Company Name: |
Myriad Genetics, Inc. |
Stock buyback: |
MYGN buyback |
Website: |
www.myriad.com |
Sector: |
Biotechnology |
Number of ETFs Holding MYGN: |
51 |
Total Market Value Held by ETFs: |
$494.96M |
Total Market Capitalization: |
$1.93B |
% of Market Cap. Held by ETFs: |
25.63% |
|
|
March 29, 2024 5:12 AM Eastern
Hold (2.36 out of 4)
0th percentile
|
|